Medical Devices Japan

Japan Preeclampsia Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Japan Preeclampsia Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Japan · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $99.5 Mn Placeholder estimate
Estimate 2025 $107.0 Mn 6.7% of the global market
Projected 2034 $205.2 Mn 91.7% Adds $98.2 Mn over 9 forecast years
CAGR 2025–2034 7.5% Faster than 28% of 173 Medical Devices markets here
Key players 5
  • Japan is 6.68% of the global market.
  • In APAC, the largest is China at $114.6 Mn.
  • Fastest growing: India at 10.4% a year.
  • Japan ranks 2nd of 10 by size in APAC.

Market size projection

Japan

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$98.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Preeclampsia Diagnostics Market market size by year, Japan
YearMarket sizeChange that yearSince 2025
2024 (estimate) $99.5 Mn — —
2025 (base) $107.0 Mn +$7.5 Mn —
2026 (forecast) $115.0 Mn +$8.0 Mn +7.5%
2027 (forecast) $123.7 Mn +$8.6 Mn +15.6%
2028 (forecast) $132.9 Mn +$9.3 Mn +24.2%
2029 (forecast) $142.9 Mn +$10.0 Mn +33.5%
2030 (forecast) $153.6 Mn +$10.7 Mn +43.6%
2031 (forecast) $165.2 Mn +$11.5 Mn +54.3%
2032 (forecast) $177.5 Mn +$12.4 Mn +65.9%
2033 (forecast) $190.9 Mn +$13.3 Mn +78.3%
2034 (forecast) $205.2 Mn +$14.3 Mn +91.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Japan Preeclampsia Diagnostics Market Analysis at a glance
Market size, 2025$107.0 Mn placeholder estimate
Forecast, 2034$205.2 Mn placeholder estimate
Growth (CAGR), 2025–20347.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, use and end user (see all)
Key playersRoche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers, Quidel Corporation (see all)
Regulator in JapanPMDASource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Japan Preeclampsia Diagnostics Market Analysis Executive Summary

Preeclampsia diagnostics are blood tests and monitoring tools that predict or detect dangerous high blood pressure in pregnancy.

Key segments of the preeclampsia Diagnostics market include test (sFlt-1/PlGF Ratio Tests, PlGF Tests and Blood Pressure Monitoring) and use (Screening, Diagnosis and Prognosis).

Bar chart: Japan Preeclampsia Diagnostics market size, 2024–2034, placeholder estimates. $99.5 Mn in 2024, $107.0 Mn in 2025 and $205.2 Mn in 2034, 7.5% CAGR.
Japan Preeclampsia Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Japan Preeclampsia Diagnostics Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the preeclampsia Diagnostics market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the preeclampsia Diagnostics market.

Competitive Landscape for Preeclampsia Diagnostics Market in Japan

The preeclampsia Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Preeclampsia Diagnostics Market in Japan

Preeclampsia Diagnostics in Japan: rules and payment

Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare.⁠[1] Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices).⁠[2]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how preeclampsia Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Japan.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Preeclampsia Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Preeclampsia Diagnostics in context

Japan compared

  • Health spending per person: 3,638 US$ per person (2023). World: 1,317 US$ per person (2023). 4th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.65 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 5th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 30.0% of people (2025). World: 10.4% of people (2025). Highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 16 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Preeclampsia Diagnostics market in Japan?
Placeholder estimate: about $107.0 Mn in 2025, rising to about $205.2 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Preeclampsia Diagnostics market in Japan growing?
Placeholder estimate: about 7.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Preeclampsia Diagnostics market report cover?
The report splits the market by test (sFlt-1/PlGF Ratio Tests, PlGF Tests, Blood Pressure Monitoring, Urine Protein Tests), use (Screening, Diagnosis, Prognosis) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Preeclampsia Diagnostics market?
Key players include Roche Diagnostics, Thermo Fisher Scientific Inc., Perkin Elmer, Siemens Healthineers and Quidel Corporation.
What is driving the Preeclampsia Diagnostics market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.
Who regulates Preeclampsia Diagnostics in Japan?
Medical devices are notified, certified or approved depending on their risk; the Pharmaceuticals and Medical Devices Agency (PMDA) reviews higher-risk devices for approval by the Ministry of Health, Labour and Welfare. Source: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
How is healthcare paid for in Japan?
Everyone is covered by public health insurance, and the Ministry of Health, Labour and Welfare sets the official price list for covered medicines (NHI prices). Source: Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.
How much research is published on Preeclampsia Diagnostics?
PubMed lists 7,556 papers on Preeclampsia Diagnostics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Japan

See all

Related on maternal and diagnostics and lab testing

See the topic